Vimarsana
Biggest News Aggregation in the World

Williamv Williams News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Williamv Williams. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Williamv Williams Today - Breaking & Trending Today

Breaking Ground in Prostate Cancer: BriaCell Announces Lead - Vimarsana News

Breaking Ground in Prostate Cancer: BriaCell Announces Lead

Bria-Pros+ is based on BriaCell’s next generation personalized immunotherapy platformBria-Pros+ is capable of activating multiple types of immune cells,...

BriaCell Therapeutics Corp. Announces Results of - Vimarsana News

BriaCell Therapeutics Corp. Announces Results of

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) (“BriaCell”...

BriaCell Images Confirm Robust Anti-Tumor Activity in - Vimarsana News

BriaCell Images Confirm Robust Anti-Tumor Activity in

Significant reduction of metastatic breast cancer tumor behind-the-eye after only 3 cyclesPowerful anti-tumor response associated with reduction in...

BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS - BriaCell Therapeutics (NASDAQ:BCTXW), BriaCell Therapeutics (NASDAQ:BCTX) - Vimarsana News

BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS - BriaCell Therapeutics (NASDAQ:BCTXW), BriaCell Therapeutics (NASDAQ:BCTX)

Median overall survival of 13.4 months in patients treated with the Bria-IMT™ combination regimen (vs. 6.7-9.8 months for similar patients reported in the literature*).32 out of 42 patients treated since 2022

BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast Cancer - Vimarsana News

BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast Cancer

PHILADELPHIA, Pa. and VANCOUVER, British Columbia, Oct. 04, 2023 -- BriaCell Therapeutics Corp. , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer...